 | • レポートコード：QFJ1-4959 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、体部白癬治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗真菌剤、ステロイド、抗感染薬組み合わせ）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・体部白癬治療薬の市場動向 ・企業の競争状況、市場シェア ・体部白癬治療薬の種類別市場規模と予測2016-2027（抗真菌剤、ステロイド、抗感染薬組み合わせ） ・体部白癬治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・体部白癬治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・体部白癬治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・体部白癬治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・体部白癬治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・体部白癬治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sun Pharmaceutical、Teva、Glenmark、Aurobindo、AvKare、Novartis、Sebela、Bayer） ・結論 |
Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.
Market Analysis and Insights: Global Tinea Corporis Drugs Market
The global Tinea Corporis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tinea Corporis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tinea Corporis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tinea Corporis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tinea Corporis Drugs market.
Global Tinea Corporis Drugs Scope and Market Size
Tinea Corporis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tinea Corporis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antifungals
Steroids
Anti-Infective Combinations
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tinea Corporis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antifungals
1.2.3 Steroids
1.2.4 Anti-Infective Combinations
1.3 Market by Application
1.3.1 Global Tinea Corporis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tinea Corporis Drugs Market Perspective (2016-2027)
2.2 Tinea Corporis Drugs Growth Trends by Regions
2.2.1 Tinea Corporis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tinea Corporis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Tinea Corporis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Tinea Corporis Drugs Industry Dynamic
2.3.1 Tinea Corporis Drugs Market Trends
2.3.2 Tinea Corporis Drugs Market Drivers
2.3.3 Tinea Corporis Drugs Market Challenges
2.3.4 Tinea Corporis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tinea Corporis Drugs Players by Revenue
3.1.1 Global Top Tinea Corporis Drugs Players by Revenue (2016-2021)
3.1.2 Global Tinea Corporis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Tinea Corporis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tinea Corporis Drugs Revenue
3.4 Global Tinea Corporis Drugs Market Concentration Ratio
3.4.1 Global Tinea Corporis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tinea Corporis Drugs Revenue in 2020
3.5 Tinea Corporis Drugs Key Players Head office and Area Served
3.6 Key Players Tinea Corporis Drugs Product Solution and Service
3.7 Date of Enter into Tinea Corporis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tinea Corporis Drugs Breakdown Data by Type
4.1 Global Tinea Corporis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Tinea Corporis Drugs Forecasted Market Size by Type (2022-2027)
5 Tinea Corporis Drugs Breakdown Data by Application
5.1 Global Tinea Corporis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Tinea Corporis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tinea Corporis Drugs Market Size (2016-2027)
6.2 North America Tinea Corporis Drugs Market Size by Type
6.2.1 North America Tinea Corporis Drugs Market Size by Type (2016-2021)
6.2.2 North America Tinea Corporis Drugs Market Size by Type (2022-2027)
6.2.3 North America Tinea Corporis Drugs Market Size by Type (2016-2027)
6.3 North America Tinea Corporis Drugs Market Size by Application
6.3.1 North America Tinea Corporis Drugs Market Size by Application (2016-2021)
6.3.2 North America Tinea Corporis Drugs Market Size by Application (2022-2027)
6.3.3 North America Tinea Corporis Drugs Market Size by Application (2016-2027)
6.4 North America Tinea Corporis Drugs Market Size by Country
6.4.1 North America Tinea Corporis Drugs Market Size by Country (2016-2021)
6.4.2 North America Tinea Corporis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tinea Corporis Drugs Market Size (2016-2027)
7.2 Europe Tinea Corporis Drugs Market Size by Type
7.2.1 Europe Tinea Corporis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Tinea Corporis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Tinea Corporis Drugs Market Size by Type (2016-2027)
7.3 Europe Tinea Corporis Drugs Market Size by Application
7.3.1 Europe Tinea Corporis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Tinea Corporis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Tinea Corporis Drugs Market Size by Application (2016-2027)
7.4 Europe Tinea Corporis Drugs Market Size by Country
7.4.1 Europe Tinea Corporis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Tinea Corporis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tinea Corporis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Tinea Corporis Drugs Market Size by Type
8.2.1 Asia-Pacific Tinea Corporis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tinea Corporis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tinea Corporis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Tinea Corporis Drugs Market Size by Application
8.3.1 Asia-Pacific Tinea Corporis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tinea Corporis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tinea Corporis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Tinea Corporis Drugs Market Size by Region
8.4.1 Asia-Pacific Tinea Corporis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tinea Corporis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tinea Corporis Drugs Market Size (2016-2027)
9.2 Latin America Tinea Corporis Drugs Market Size by Type
9.2.1 Latin America Tinea Corporis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Tinea Corporis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Tinea Corporis Drugs Market Size by Type (2016-2027)
9.3 Latin America Tinea Corporis Drugs Market Size by Application
9.3.1 Latin America Tinea Corporis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Tinea Corporis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Tinea Corporis Drugs Market Size by Application (2016-2027)
9.4 Latin America Tinea Corporis Drugs Market Size by Country
9.4.1 Latin America Tinea Corporis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Tinea Corporis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tinea Corporis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Tinea Corporis Drugs Market Size by Type
10.2.1 Middle East & Africa Tinea Corporis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tinea Corporis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tinea Corporis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Tinea Corporis Drugs Market Size by Application
10.3.1 Middle East & Africa Tinea Corporis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tinea Corporis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tinea Corporis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Tinea Corporis Drugs Market Size by Country
10.4.1 Middle East & Africa Tinea Corporis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tinea Corporis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sun Pharmaceutical
11.1.1 Sun Pharmaceutical Company Details
11.1.2 Sun Pharmaceutical Business Overview
11.1.3 Sun Pharmaceutical Tinea Corporis Drugs Introduction
11.1.4 Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2016-2021)
11.1.5 Sun Pharmaceutical Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Tinea Corporis Drugs Introduction
11.2.4 Teva Revenue in Tinea Corporis Drugs Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Glenmark
11.3.1 Glenmark Company Details
11.3.2 Glenmark Business Overview
11.3.3 Glenmark Tinea Corporis Drugs Introduction
11.3.4 Glenmark Revenue in Tinea Corporis Drugs Business (2016-2021)
11.3.5 Glenmark Recent Development
11.4 Aurobindo
11.4.1 Aurobindo Company Details
11.4.2 Aurobindo Business Overview
11.4.3 Aurobindo Tinea Corporis Drugs Introduction
11.4.4 Aurobindo Revenue in Tinea Corporis Drugs Business (2016-2021)
11.4.5 Aurobindo Recent Development
11.5 AvKare
11.5.1 AvKare Company Details
11.5.2 AvKare Business Overview
11.5.3 AvKare Tinea Corporis Drugs Introduction
11.5.4 AvKare Revenue in Tinea Corporis Drugs Business (2016-2021)
11.5.5 AvKare Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Tinea Corporis Drugs Introduction
11.6.4 Novartis Revenue in Tinea Corporis Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sebela
11.7.1 Sebela Company Details
11.7.2 Sebela Business Overview
11.7.3 Sebela Tinea Corporis Drugs Introduction
11.7.4 Sebela Revenue in Tinea Corporis Drugs Business (2016-2021)
11.7.5 Sebela Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Tinea Corporis Drugs Introduction
11.8.4 Bayer Revenue in Tinea Corporis Drugs Business (2016-2021)
11.8.5 Bayer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tinea Corporis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antifungals
Table 3. Key Players of Steroids
Table 4. Key Players of Anti-Infective Combinations
Table 5. Global Tinea Corporis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tinea Corporis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Tinea Corporis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Tinea Corporis Drugs Market Share by Regions (2016-2021)
Table 9. Global Tinea Corporis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Tinea Corporis Drugs Market Share by Regions (2022-2027)
Table 11. Tinea Corporis Drugs Market Trends
Table 12. Tinea Corporis Drugs Market Drivers
Table 13. Tinea Corporis Drugs Market Challenges
Table 14. Tinea Corporis Drugs Market Restraints
Table 15. Global Tinea Corporis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Tinea Corporis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Corporis Drugs as of 2020)
Table 18. Ranking of Global Top Tinea Corporis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Tinea Corporis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tinea Corporis Drugs Product Solution and Service
Table 22. Date of Enter into Tinea Corporis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Tinea Corporis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Tinea Corporis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Tinea Corporis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Tinea Corporis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Tinea Corporis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Tinea Corporis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Tinea Corporis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Tinea Corporis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Tinea Corporis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Tinea Corporis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Tinea Corporis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Tinea Corporis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Tinea Corporis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Tinea Corporis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Tinea Corporis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Tinea Corporis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Tinea Corporis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Tinea Corporis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Tinea Corporis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Tinea Corporis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Tinea Corporis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Tinea Corporis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Tinea Corporis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Tinea Corporis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Tinea Corporis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Tinea Corporis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Tinea Corporis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Tinea Corporis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Tinea Corporis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Tinea Corporis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Tinea Corporis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Tinea Corporis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Tinea Corporis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sun Pharmaceutical Company Details
Table 63. Sun Pharmaceutical Business Overview
Table 64. Sun Pharmaceutical Tinea Corporis Drugs Product
Table 65. Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 66. Sun Pharmaceutical Recent Development
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Tinea Corporis Drugs Product
Table 70. Teva Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Glenmark Company Details
Table 73. Glenmark Business Overview
Table 74. Glenmark Tinea Corporis Drugs Product
Table 75. Glenmark Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 76. Glenmark Recent Development
Table 77. Aurobindo Company Details
Table 78. Aurobindo Business Overview
Table 79. Aurobindo Tinea Corporis Drugs Product
Table 80. Aurobindo Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 81. Aurobindo Recent Development
Table 82. AvKare Company Details
Table 83. AvKare Business Overview
Table 84. AvKare Tinea Corporis Drugs Product
Table 85. AvKare Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 86. AvKare Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Tinea Corporis Drugs Product
Table 90. Novartis Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Sebela Company Details
Table 93. Sebela Business Overview
Table 94. Sebela Tinea Corporis Drugs Product
Table 95. Sebela Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 96. Sebela Recent Development
Table 97. Bayer Company Details
Table 98. Bayer Business Overview
Table 99. Bayer Revenue in Tinea Corporis Drugs Business (2016-2021) & (US$ Million)
Table 100. Bayer Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tinea Corporis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antifungals Features
Figure 3. Steroids Features
Figure 4. Anti-Infective Combinations Features
Figure 5. Global Tinea Corporis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Tinea Corporis Drugs Report Years Considered
Figure 10. Global Tinea Corporis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Tinea Corporis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Tinea Corporis Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Tinea Corporis Drugs Market Share by Regions (2022-2027)
Figure 14. Global Tinea Corporis Drugs Market Share by Players in 2020
Figure 15. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Corporis Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Tinea Corporis Drugs Revenue in 2020
Figure 17. Global Tinea Corporis Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Tinea Corporis Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Tinea Corporis Drugs Market Share by Type (2016-2027)
Figure 21. North America Tinea Corporis Drugs Market Share by Application (2016-2027)
Figure 22. North America Tinea Corporis Drugs Market Share by Country (2016-2027)
Figure 23. United States Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Tinea Corporis Drugs Market Share by Type (2016-2027)
Figure 27. Europe Tinea Corporis Drugs Market Share by Application (2016-2027)
Figure 28. Europe Tinea Corporis Drugs Market Share by Country (2016-2027)
Figure 29. Germany Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Tinea Corporis Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Tinea Corporis Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Tinea Corporis Drugs Market Share by Region (2016-2027)
Figure 39. China Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Tinea Corporis Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Tinea Corporis Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Tinea Corporis Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Tinea Corporis Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Tinea Corporis Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Tinea Corporis Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Tinea Corporis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sun Pharmaceutical Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 60. Glenmark Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 61. Aurobindo Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 62. AvKare Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 64. Sebela Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Tinea Corporis Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
体部白癬用薬のグローバル市場：規模・現状・予測2019-2025 Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ …- 体部白癬用薬のグローバル市場：規模・現状・予測2019-2025 Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ …
- 世界の心理療法薬市場規模・現状・予測（2021年-2027年） Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties. Market Analysis and Insights: Global Psychotherapeutic Drugs Market The global Psychotherapeutic Drugs market size is projected to reach US$ XX million by 2027…
- 世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…